Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. NEOFORDEX (dexaméthasone (acétate de))
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

NEOFORDEX (dexaméthasone (acétate de))

Medicine - Posted on Jan 29 2020
Active substance (DCI)
  • dexaméthasone (acétate de)
history (2)
  • 1/8/20

    NEOFORDEX (dexaméthasone (acétate de))

    Identification d’alternative thérapeutique prise en charge Il existe des alternatives thérapeutiques prises en charge par l’...
    icône flèche
  • 10/19/16

    NEOFORDEX (dexamethasone), glucocorticoid

    Minor clinical added value for this medicine based on dexamethasone at 40 mg compared to DECTANCYL (dexamethasone 0.5 mg) in...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • H02AB02
Manufacturer
CTRS
Presentation

NEOFORDEX 40 mg, comprimé (code CIS : 68572869)
10 plaquette(s) polyamide aluminium PVC-Aluminium de 1 comprimé(s) - Code CIP : 34009 300 489 3 1

All our publications
    Drug therapy Hematologic cancers

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
406r82CkcHHmmeFE